NAFLD (Non-Alcohol Fatty Liver Disease) Activity Score
The NAFLD Activity Score quantifies histologic disease activity by summing steatosis, lobular inflammation, and hepatocellular ballooning 1.
Indications for Use
Used to grade histologic disease activity on liver biopsy by summing steatosis, lobular inflammation, and ballooning to quantify NASH severity only for clinical trials and tracking histologic change, not for diagnosing NASH (poor specificity) 1 [Level I evidence]; misclassification risk shown in a 976‑patient cohort 2 [Level II evidence]. Guides treatment endpoints (e.g., ≥2‑point NAS improvement without fibrosis worsening) 3 [Level III evidence].
Insights & Cautions
Reflects biopsy‑graded steatosis, lobular inflammation, and ballooning to track histologic activity, but does not diagnose NASH and should not be used alone for clinical decision‑making 1 [Level III evidence]. Interpretation is limited by sampling error and interobserver variability 2 [Level III evidence]. Higher scores correlate with enzymes and disease activity but poorly predict outcomes, as fibrosis—not NAS—drives prognosis 3 [Level II evidence].